Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
This study has been completed.
Information provided by:
First received: May 27, 2008
Last updated: February 12, 2009
Last verified: February 2009
To prove the safety, in normal conditions, of the odontological use formulation of the product Cepacol Canela Power.
|Study Design:||Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Uni Centric Study, Phase III, for Safety Oral Mucosa Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Canela Power|
Resource links provided by NLM:
Further study details as provided by Sanofi:
Primary Outcome Measures:
- Patients will be evaluated according to the adverse reactions and the intensity of them. The volunteers will also answer a questionnaire about the physical attributes of the product. [ Time Frame: 21 days ] [ Designated as safety issue: Yes ]
|Study Start Date:||January 2008|
|Primary Completion Date:||February 2008 (Final data collection date for primary outcome measure)|
Cetylpyridinium chloride during 21 days.
|Drug: Cetylpyridinium chloride|
Contacts and Locations